PTX3 and breast carcinoma: However, the synthetic PTX3 peptide inhibitors RI37 and AD9 and the PTX3NA protein dramatically inhibited PTX3‐induced signalling and downstream gene activation and inhibited the protumour effects of sphere formation and migration/invasion in breast cancer.